These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 15261949)
1. Wanted! The best cell for cardiac regeneration. Dimmeler S; Zeiher AM J Am Coll Cardiol; 2004 Jul; 44(2):464-6. PubMed ID: 15261949 [No Abstract] [Full Text] [Related]
2. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. Agbulut O; Vandervelde S; Al Attar N; Larghero J; Ghostine S; Léobon B; Robidel E; Borsani P; Le Lorc'h M; Bissery A; Chomienne C; Bruneval P; Marolleau JP; Vilquin JT; Hagège A; Samuel JL; Menasché P J Am Coll Cardiol; 2004 Jul; 44(2):458-63. PubMed ID: 15261948 [TBL] [Abstract][Full Text] [Related]
3. Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure. Bonaros N; Rauf R; Werner E; Schlechta B; Rohde E; Kocher A; Bonatti J; Laufer G Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):249-55. PubMed ID: 17925321 [TBL] [Abstract][Full Text] [Related]
4. A Caveat Emptor for myocardial regeneration: mechanical without electrical recovery will not suffice. Cohen IS; Rosen AB; Gaudette GR J Mol Cell Cardiol; 2007 Feb; 42(2):285-8. PubMed ID: 17196613 [No Abstract] [Full Text] [Related]
5. [Expression of AC133 vs. CD34 in acute childhood leukemias]. Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777 [TBL] [Abstract][Full Text] [Related]
6. Stem cells show mixed results in MI patients. Kahn J J Interv Cardiol; 2006 Aug; 19(4):297-301. PubMed ID: 16881973 [No Abstract] [Full Text] [Related]
7. Stem cell therapy for the broken heart: mini-organ transplantation. Mansour S; Roy DC; Lemieux B; Ouellet C; Stevens LM; Noiseux N Transplant Proc; 2009 Oct; 41(8):3353-7. PubMed ID: 19857748 [TBL] [Abstract][Full Text] [Related]
8. [Cardiac cell therapy: the puzzle is waiting to be solved]. Canepa M; Coviello D; Chiarella F G Ital Cardiol (Rome); 2006 Apr; 7(4):252-65. PubMed ID: 16700408 [TBL] [Abstract][Full Text] [Related]
10. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Bartunek J; Vanderheyden M; Vandekerckhove B; Mansour S; De Bruyne B; De Bondt P; Van Haute I; Lootens N; Heyndrickx G; Wijns W Circulation; 2005 Aug; 112(9 Suppl):I178-83. PubMed ID: 16159812 [TBL] [Abstract][Full Text] [Related]
11. Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats. Ott HC; Bonaros N; Marksteiner R; Wolf D; Margreiter E; Schachner T; Laufer G; Hering S Eur J Cardiothorac Surg; 2004 Apr; 25(4):627-34. PubMed ID: 15037282 [TBL] [Abstract][Full Text] [Related]
12. Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction. Manginas A; Goussetis E; Koutelou M; Karatasakis G; Peristeri I; Theodorakos A; Leontiadis E; Plessas N; Theodosaki M; Graphakos S; Cokkinos DV Catheter Cardiovasc Interv; 2007 May; 69(6):773-81. PubMed ID: 17394248 [TBL] [Abstract][Full Text] [Related]
13. Risk and benefit of CD133+ progenitors. Ascione R; Madeddu P Circ Res; 2009 Jul; 105(2):e2. PubMed ID: 19608984 [No Abstract] [Full Text] [Related]
14. Cell transplantation for myocardial regeneration: hype or reality? Björquist P; Jeppsson A Scand Cardiovasc J; 2004 Oct; 38(5):259-64. PubMed ID: 15513307 [No Abstract] [Full Text] [Related]
15. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy. Memon IA; Sawa Y; Miyagawa S; Taketani S; Matsuda H J Thorac Cardiovasc Surg; 2005 Sep; 130(3):646-53. PubMed ID: 16153908 [TBL] [Abstract][Full Text] [Related]
17. Autologous myoblasts transplantation improves heart function after myocardiac infarction. Zhuang W; Li L; Lin G; Deng Z Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 36(4):286-93. PubMed ID: 21566278 [TBL] [Abstract][Full Text] [Related]
18. Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Tongers J; Losordo DW; Landmesser U Eur Heart J; 2011 May; 32(10):1197-206. PubMed ID: 21362705 [TBL] [Abstract][Full Text] [Related]
19. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery. Klein HM; Ghodsizad A; Marktanner R; Poll L; Voelkel T; Mohammad Hasani MR; Piechaczek C; Feifel N; Stockschlaeder M; Burchardt ER; Kar BJ; Gregoric I; Gams E Heart Surg Forum; 2007; 10(1):E66-9. PubMed ID: 17162408 [TBL] [Abstract][Full Text] [Related]